US biotechnology company Gilead Sciences has made a commitment to reduce its greenhouse gas emissions by 25% by 2025.
It believes the impact of climate change on “under-deserved and at-risk populations” has enormous implications on global health, including increasing transmission of serious diseases, compounding health risks for the young and elderly and greater danger for those already immune-compromised.
It is therefore making the pledge in line with the Paris Agreement’s central aim of keeping global temperature rise to below 2°C.
future Net Zero is a free site but we’d ask you to login one time to access the content.
You will also be subscribed to our newsletter service, which will offer insight and editorial commentary, you are free to unsubscribe at anytime.
You can sign up using:
Or simply create an account